M J Bevan

3.8k total citations · 2 hit papers
25 papers, 3.2k citations indexed

About

M J Bevan is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M J Bevan has authored 25 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M J Bevan's work include T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (11 papers). M J Bevan is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (11 papers). M J Bevan collaborates with scholars based in United States and Switzerland. M J Bevan's co-authors include Stephen C. Jameson, Marc A. Gavin, John T. Harty, Kristin A. Hogquist, Uwe D. Staerz, Stefan F. Martin, Peter Brossart, Roger M. Perlmutter, Kathryn A. Swan and José Alberola‐Ila and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Immunity.

In The Last Decade

M J Bevan

25 papers receiving 3.0k citations

Hit Papers

Cross-priming for a secondary cytotoxic response to minor... 1975 2026 1992 2009 1976 1975 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M J Bevan United States 19 2.6k 689 469 452 221 25 3.2k
Mary T. Crowley United States 19 3.0k 1.1× 739 1.1× 336 0.7× 400 0.9× 204 0.9× 21 3.5k
Suzanne B. Hartley United States 14 2.9k 1.1× 633 0.9× 349 0.7× 486 1.1× 220 1.0× 14 3.5k
Donal B. Murphy United States 31 2.9k 1.1× 892 1.3× 281 0.6× 1.1k 2.5× 191 0.9× 62 3.7k
Mary Trounstine United States 16 1.4k 0.5× 668 1.0× 452 1.0× 609 1.3× 366 1.7× 18 2.4k
Joel M. Depper United States 11 1.8k 0.7× 419 0.6× 386 0.8× 384 0.8× 314 1.4× 14 2.6k
Jhagvaral Hasbold Australia 24 2.3k 0.9× 786 1.1× 335 0.7× 259 0.6× 145 0.7× 29 3.0k
Danita H. Schuurhuis Netherlands 26 1.9k 0.7× 888 1.3× 928 2.0× 405 0.9× 231 1.0× 36 2.8k
Barry J. Skidmore United States 14 1.6k 0.6× 495 0.7× 235 0.5× 598 1.3× 151 0.7× 20 2.2k
M. Hadam Germany 24 1.2k 0.5× 576 0.8× 413 0.9× 226 0.5× 152 0.7× 66 2.0k
E G Engleman United States 22 1.4k 0.5× 484 0.7× 206 0.4× 404 0.9× 251 1.1× 31 2.0k

Countries citing papers authored by M J Bevan

Since Specialization
Citations

This map shows the geographic impact of M J Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J Bevan more than expected).

Fields of papers citing papers by M J Bevan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J Bevan. The network helps show where M J Bevan may publish in the future.

Co-authorship network of co-authors of M J Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of M J Bevan. A scholar is included among the top collaborators of M J Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J Bevan. M J Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Talyn, Aaron J. Tyznik, Amy M. Berkley, et al.. (2013). Bystander-Activated Memory CD8 T Cells Control Early Pathogen Load in an Innate-like, NKG2D-Dependent Manner. Cell Reports. 3(3). 701–708. 141 indexed citations
3.
Martin, Stefan F. & M J Bevan. (1997). Antigen‐specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. European Journal of Immunology. 27(10). 2726–2736. 85 indexed citations
4.
Brossart, Peter & M J Bevan. (1996). Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide.. The Journal of Experimental Medicine. 183(6). 2449–2458. 85 indexed citations
5.
Alberola‐Ila, José, Kristin A. Hogquist, Kathryn A. Swan, M J Bevan, & Roger M. Perlmutter. (1996). Positive and negative selection invoke distinct signaling pathways.. The Journal of Experimental Medicine. 184(1). 9–18. 208 indexed citations
6.
Jameson, Stephen C. & M J Bevan. (1995). T cell receptor antagonists and partial agonists. Immunity. 2(1). 1–11. 263 indexed citations
7.
Gavin, Marc A. & M J Bevan. (1995). Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity. 3(6). 793–800. 122 indexed citations
8.
Hogquist, Kristin A., Marc A. Gavin, & M J Bevan. (1993). Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture.. The Journal of Experimental Medicine. 177(5). 1469–1473. 201 indexed citations
9.
Grandea, Andres G. & M J Bevan. (1993). A conservative mutation in a class I MHC molecule outside the peptide binding groove stimulates responses to self peptides.. The Journal of Immunology. 151(8). 3981–3987. 7 indexed citations
10.
Harty, John T. & M J Bevan. (1992). CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo.. The Journal of Experimental Medicine. 175(6). 1531–1538. 225 indexed citations
11.
Grandea, Andres G. & M J Bevan. (1992). Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides.. Proceedings of the National Academy of Sciences. 89(7). 2794–2798. 38 indexed citations
12.
Staerz, Uwe D. & M J Bevan. (1989). Redirecting the Cellular Immune Response. International Reviews of Immunology. 4(2). 159–173. 6 indexed citations
13.
Staerz, Uwe D. & M J Bevan. (1986). Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.. Proceedings of the National Academy of Sciences. 83(5). 1453–1457. 163 indexed citations
14.
Staerz, Uwe D. & M J Bevan. (1986). Targeting cells for attack by cytotoxic T lymphocytes using heteroconjugates of monoclonal antibodies.. PubMed. 38. 31–4. 1 indexed citations
15.
Lefrançois, Leo, Lynn Puddington, Carolyn E. Machamer, & M J Bevan. (1985). Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens.. The Journal of Experimental Medicine. 162(4). 1275–1293. 62 indexed citations
16.
Hamilton, Betty L., M J Bevan, & Robertson Parkman. (1981). Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.. The Journal of Immunology. 126(2). 621–625. 69 indexed citations
17.
Fink, Pamela J. & M J Bevan. (1981). Influence of H-2 antigen expression on killer T cell specificity, differentiation, and induction.. Proceedings of the National Academy of Sciences. 78(10). 6401–6405. 7 indexed citations
18.
Bevan, M J. (1977). Killer cells reactive to altered-self antigens can also be alloreactive.. Proceedings of the National Academy of Sciences. 74(5). 2094–2098. 135 indexed citations
19.
Bevan, M J. (1976). Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.. The Journal of Experimental Medicine. 143(5). 1283–1288. 737 indexed citations breakdown →
20.
Bevan, M J. (1975). The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.. The Journal of Experimental Medicine. 142(6). 1349–1364. 411 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026